Closure of Trading Window
23-Mar-2026 | Source : BSEThis is to Inform that pursuant to SEBI (PIT) Regulations 2015 read with the relevant Circulars issued by BSE Limited and Companies Code of Conduct for prevention of Insider Trading of the Company the Trading window for dealing in shares of the Company for all designated persons and their Immediate Relatives shall remain Closed from 1st April 2026 till 48 Hours after the Decleration of financial results for the Quarter and Year ended 31st March 2026. The date of the Board meeting for the consideration of the Financial Results of the Company for the Quarter ended 31st March 2026 will be intimated in due course.
Announcement under Regulation 30 (LODR)-Resignation of Director
17-Mar-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 We wish to inform you that Mr. Hemant Amrish Parikh (DIN: 00027820) has tendered his resignation as Non-Executive Director of the Company vide letter dated March 17th 2026 effective from the close of business hours on the same date citing personal reasons. The details required under Regulation 30 read with SEBI Circular are provided in Annexure-A. Further the Company has received confirmation from Mr. H.A. Parikh that there are no material reasons for his resignation other than those stated in his resignation letter dated March 17 2026 which is enclosed as Annexure-B
Announcement under Regulation 30 (LODR)-Change in Directorate
17-Mar-2026 | Source : BSEDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding intimation of Resignation of Mr. Hemant Amrish Parikh as Non-Executive Director with Effect from 17/03/2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Vivanza Biosciences Ltd has announced 1:10 stock split, ex-date: 24 Mar 23
No Bonus history available
No Rights history available